Else Nutrition

Else Nutrition (TSX: BABY) reported Q1 2025 results with steady revenue of $2.1 million CAD. Operating expenses decreased by 48%, leading to a gross profit increase to $0.5 million CAD and a gross margin of 25%. The company is focusing on cost reduction by moving powder formula manufacturing to Europe, strengthening retail partnerships, and advancing plant-based infant nutrition through regulatory channels. A conference call to discuss the results is scheduled for today at 10:00 AM Eastern Time.